Results per Page:
Metagenomic sequencing uncovers SARS-CoV-2 co-infections
From the University of Washington and the Jerome lab, Vaccine and Infectious Disease Division
What happens when cancer patients get COVID-19?
Large new observational study of nearly 1,000 patients breaks down who’s most at risk with coronavirus, highlights need for additional care
Structural and clinical barriers keep 3 of 4 cancer patients from participating in trials
‘Patients are willing to participate in trials if they’re offered one’
Comorbidities impede clinical trial participation
From the Unger Group, Public Health Sciences Division
How to boost cancer clinical trial participation
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients